{"id":376924,"date":"2026-03-10T02:56:28","date_gmt":"2026-03-10T02:56:28","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/376924\/"},"modified":"2026-03-10T02:56:28","modified_gmt":"2026-03-10T02:56:28","slug":"apply-now-60-million-for-ai-decision-support-tool-evaluations","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/376924\/","title":{"rendered":"Apply Now: $60 Million for AI Decision Support Tool Evaluations"},"content":{"rendered":"\n

\u21d3 More from ICTworks<\/p>\n


\n\t\t\t\t\t\tBy Wayan Vota on March 9, 2026 \n\t\t\t\t\t<\/p>\n

\"artificial<\/p>\n

The evidence crisis in artificial intelligence for health is stark<\/a>.\u00a0AI-powered triage assistants, diagnostic aids, and LLM-based symptom checkers are being deployed from Kenya to Myanmar \u2014 but without rigorous local evidence.<\/p>\n

Of 86 randomized clinical trials on AI health tools conducted globally between 2018 and 2023, only four took place in low- and middle-income countries (LMICs) \u2014 the settings where overburdened community health workers and primary care clinicians arguably need decision support most.<\/p>\n

Governments across the region cannot confidently adopt or scale tools that haven\u2019t been tested in their own clinical environments, languages, and workflow realities. Promising tools risk failing to move from proof-of-concept to real-world impact, wasting investments, and widening health care disparities.<\/p>\n

$60 Million Funding from Gates, Welcome, Novo<\/p>\n

The Evidence for AI in Health initiative<\/a> is accepting proposals to evaluate AI-enabled clinical decision support tools already used by frontline workers in Sub-Saharan Africa, South Asia, and Southeast Asia.<\/p>\n

EVAH\u00a0 is backed by Wellcome Trust, the Gates Foundation, and the Novo Nordisk Foundation to fund two different pathways for promising AI-enabled clinical decision support tools.<\/p>\n